FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.09-131607.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.09-131607v1
23/11/3712    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lee, N. Y.
Right arrow Articles by Blobe, G. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, N. Y.
Right arrow Articles by Blobe, G. C.
(The FASEB Journal. 2009;23:3712-3721.)
© 2009 FASEB

Casein kinase 2β as a novel enhancer of activin-like receptor-1 signaling

Nam Y. Lee*,1, John C. Haney{dagger},1, Julie Sogani* and Gerard C. Blobe*,{ddagger},2

* Department of Medicine,

{dagger} Department of Surgery, and

{ddagger} Department of Pharmacology and Cancer Biology, Duke University, Durham, NC, USA

2 Correspondence: Box 91004, Research Dr., B534 LSRC, Durham, NC 27708, USA. E-mail: gerard.blobe{at}duke.edu

ALK-1 is a transforming growth factor β (TGF-β) superfamily receptor that is predominantly expressed in endothelial cells and is essential for angiogenesis, as demonstrated by the embryonic lethal phentoype when targeted for deletion in mice and its mutation in the human disease hereditary hemorrhagic telangiectasia. Although ALK-1 and the endothelial-specific TGF-β superfamily coreceptor, endoglin, form a heteromeric complex and bind similar TGF-β superfamily ligands, their signaling mechanisms remain poorly characterized. Here we report the identification of CK2β, the regulatory subunit of protein kinase CK2, as a novel enhancer of ALK-1 signaling. The cytoplasmic domain of ALK-1 specifically binds to CK2β in vitro and in vivo. NAAIRS mutagenesis studies define amino acid sequences 181–199 of CK2β and 207–212 of ALK-1 as the interaction domains, respectively. The ALK-1/CK2β interaction specifically enhanced Smad1/5/8 phosphorylation and ALK-1-mediated reporter activation in response to TGF-β1 and BMP-9 treatment. In a reciprocal manner, siRNA-mediated silencing of endogenous CK2β inhibited TGF-β1 and BMP-9-stimulated Smad1/5/8 phosphorylation and ALK-1-mediated reporter activation. Functionally, CK2β enhanced the ability of activated or ligand-stimulated ALK-1 to inhibit endothelial cell migration. Similarly, ALK-1 and CK2β antagonized endothelial tubule formation in Matrigel. These studies support CK2β as an important regulator of ALK-1 signaling and ALK-1-mediated functions in endothelial cells.—Lee, N. Y., Haney, J. C., Sogani, J., Blobe, G. C. Casein kinase 2β as a novel enhancer of activin-like receptor-1 signaling.


Key Words: TGF-β superfamily signaling • endothelial cell biology • angiogenesis • bone morphogenetic protein • migration







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.